Immunotherapy toxicity in patients over 65 years.

被引:1
|
作者
Mendez, Miriam
Cantos, Blanca
Nunez, Beatriz
Nunez Garcia, Beatriz
Cristobal Sanchez, Juan
Franco, Fernando
Maximiano, Constanza
Gutierrez, Lourdes
De La Puente, Blanca
Ruiz Casado, Ana
Provencio, Mariano
机构
[1] Hosp Puerta Hierro, Majadahonda, Spain
[2] Clin Puerta Hierro, Madrid, Spain
[3] Hosp Puerta Hierro Majadahonda, Madrid, Spain
[4] Hosp Univ Puerta Hierro, Majadahonda, Spain
[5] Univ Hosp Puerta Hierro Majadahonda, Dept Med Oncol, Madrid, Spain
[6] Hosp Univ Puerta Hierro, Madrid, Spain
[7] Hosp Univ Puerta Hierro Majadahonda, Madrid, Spain
[8] Hosp Univ Puerta Hierro Majadahonda, Dept Med Oncol, Madrid, Spain
[9] Puerta Hierro Majadahonda Univ Hosp, Madrid, Spain
关键词
D O I
10.1200/JCO.2021.39.15_suppl.12027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
12027
引用
收藏
页数:4
相关论文
共 50 条
  • [11] Real-world data of immunotherapy in patients over 65 years old with lung cancer
    Nunez-Garcia, B.
    Garitaonaindia Diaz, Y.
    Martinez-Cutillas, M.
    Blanco, M.
    Aguado, R.
    Morito Aguilar, A. M.
    Traseira, C.
    Visedo, G.
    Calvo, V.
    Franco, F.
    Provencio Pulla, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S1439 - S1439
  • [12] Real World Data: Immunotherapy in Lung Cancer Patients over 65 Years Old in Spain
    Nunez-Garcia, B.
    Blanco Clemente, M.
    Garitaonaindia, Y.
    Aguado Noya, R.
    Morito Aguilar, A.
    Traseira, C.
    Martinez, M.
    Visedo, G.
    Calvo, V.
    Franco, F.
    Provencio, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S557 - S558
  • [13] Characteristics and outcome of polyarteritis nodosa (PAN) and Churg Strauss angiitis (CSA) in 38 patients over 65 years.
    Mouthon, L
    Le Toumelin, P
    Gayraud, M
    Guillevin, L
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S369 - S369
  • [14] Prediction of patients requiring treatment over 5 years.
    Worthington, HV
    Clarkson, JE
    Blinkhorn, AS
    Davies, RM
    JOURNAL OF DENTAL RESEARCH, 1998, 77 : 652 - 652
  • [15] Short-Term Mechanical Circulatory Support Over 65 Years. Is It Worth the Effort?
    Sandoval, E.
    Sbraga, F.
    Eixeres, A.
    Villar, S.
    Perez Guillen, M.
    Morales-Rey, I.
    Garcia Alcalde, L.
    Perez de la Sota, E.
    Sarralde, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S278 - S278
  • [16] Trends in oncology trials termination due to toxicity over a period of 16 years.
    Vidal, Laura
    Curtis, Kelly Kevelin
    Vidal-Fisher, Liat
    Kos, Gabor
    Moss, Keren Rachel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [17] DOSE INTENSITY AND TOXICITY OF ADJUVANT XELOX AND FOLFOX IN OVER 65 YEARS COLON CANCER PATIENTS
    Romano, Giampiero
    Colonna, Maria
    Gnoni, Antonio
    Leo, Silvana
    Forcignano, Rosachiara
    Nuzzo, Claudio
    Luccardi, Flavia
    Veltri, Enzo
    Lorusso, Vito
    ANNALS OF ONCOLOGY, 2011, 22 : v119 - v119
  • [18] PUMP DEVELOPMENT OVER THE YEARS.
    Anderson, Harold H.
    World Pumps, 1987, : 17 - 19
  • [19] IMPACT OF THE INCORPORATION OF BORTEZOMIB, THALIDOMIDE AND LENALIDOMIDE ON THE FIRST LINE TREATMENT OF PATIENTS WITH MYELOMA FOR OVER 65 YEARS. UNICENTRIC STUDY
    Clara, Maluquer
    Mireia, Morgades
    Cristina, Motllo
    Laura, Abril
    Monica, Linares
    Ana, Triguero
    Edurne, Sarrate
    Susana, Vives
    Montserrat, Batlle
    Miriam, Moreno
    Javier, Grau
    Tomas, Navarro
    Jordi, Junca
    Fuensanta, Milla
    Evarist, Feliu
    Josep Maria, Ribera
    Albert, Oriol
    HAEMATOLOGICA, 2016, 101 : 98 - 98
  • [20] Prevalence of dynapenia in patients over 65 years
    Saez Moreno, Miguel Angel
    Jimenez Lorenzo, Ruben
    Lueso Moreno, Manuel
    Lopez-Torres Hidalgo, Jesus
    ATENCION PRIMARIA, 2018, 50 (09): : 567 - 568